Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Concentrix (CNXC) EBT (2020 - 2026)

Concentrix (CNXC) has disclosed EBT for 7 consecutive years, with $28.7 million as the latest value for Q1 2026.

  • Quarterly EBT fell 71.49% to $28.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$1.3 billion through Feb 2026, down 483.29% year-over-year, with the annual reading at -$1.2 billion for FY2025, 495.03% down from the prior year.
  • EBT hit $28.7 million in Q1 2026 for Concentrix, up from -$1.4 billion in the prior quarter.
  • In the past five years, EBT ranged from a high of $162.6 million in Q4 2022 to a low of -$1.4 billion in Q4 2025.
  • Historically, EBT has averaged $9.4 million across 5 years, with a median of $106.0 million in 2023.
  • Biggest YoY gain for EBT was 321.88% in 2025; the steepest drop was 1380.87% in 2025.
  • Year by year, EBT stood at $162.6 million in 2022, then crashed by 52.57% to $77.1 million in 2023, then soared by 46.42% to $112.9 million in 2024, then plummeted by 1380.87% to -$1.4 billion in 2025, then soared by 101.99% to $28.7 million in 2026.
  • Business Quant data shows EBT for CNXC at $28.7 million in Q1 2026, -$1.4 billion in Q4 2025, and $111.4 million in Q3 2025.